LMR Partners’s Pfizer PFE Stock Holding History

LMR Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500,000	Closed	-$12.4M	–	1771
2025 Q4	$12.4M	Hold	500,000	–	–	0.02%	305
2025 Q3	$12.7M	Hold	500,000	–	–	0.06%	259
2025 Q2	$12.1M	Hold	500,000	–	–	0.09%	238
2025 Q1	$12.7M	Hold	500,000	–	–	0.12%	195
2024 Q4	$13.3M	Buy	500,000 +375,000	+300%	+$10.2M	0.11%	182
2024 Q3	$3.62M	Buy	+125,000	New	+$3.65M	0.03%	442
2023 Q4	–	Sell	-498,300	Closed	-$16.5M	–	1097
2023 Q3	$16.5M	Sell	498,300 -50,000	-9%	-$1.77M	0.19%	125
2023 Q2	$20.1M	Buy	+548,300	New	+$21.3M	0.22%	102
2022 Q2	–	Sell	-1,227,100	Closed	-$63.5M	–	1418
2022 Q1	$63.5M	Buy	+1,227,100	New	+$63.7M	0.74%	16

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LMR Partners's PFE Position: Q2 2026 in Review

LMR Partners increased its Pfizer (PFE) stake by 553% in Q2 2026, buying an estimated $5.78M and bringing the position to 260,990 shares worth $6.28M. The position accounts for 0.02% of the portfolio, ranked #571.

LMR Partners first reported a position in PFE in Q4 2015 and has held it in 18 quarters since. The position peaked at $16.9M in Q4 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

LMR Partners held 260,990 shares of Pfizer worth $6.28M as of Q2 2026.
LMR Partners bought 221,001 Pfizer shares in Q2 2026, an estimated $5.78M.
Pfizer made up 0.02% of LMR Partners's portfolio in Q2 2026, its #571 holding.
LMR Partners first reported a position in Pfizer in Q4 2015 and has held it in 18 quarters since.
LMR Partners's Pfizer position peaked at $16.9M in Q4 2024.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.